logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
02/09/2025
According to Every AI News, Pacific Securities released a research report on September 2 giving a buy rating to Kelun Pharmaceutical (002422.SZ). The rating reasons mainly include: 1) Q2 revenue side showed improvement on a quarter-on-quarter basis, with a 6.90% increase; 2) Q2 gross margin improved on a quarter-on-quarter basis, with a slight increase in expense ratio during H1 period; 3) the innovative drug pipeline is entering the harvest period, and the results are gradually being realized. (Daily Economic News)
Latest
4 m ago
The Apollo Global Plan establishes a $5 billion sports fund.
5 m ago
Indian Nifty Energy Index expands its gains, rising by 1.2% currently.
5 m ago
Japanese companies are issuing global bonds one after another, with the total issuance size poised to set a new record exceeding one trillion US dollars.
5 m ago
With more Japanese companies issuing bonds in the primary market on Tuesday, the total amount of US dollar and Euro bonds issued by Japanese issuers this year is expected to exceed $100 billion, setting a new record. At least seven Japanese companies, including Nomura Holdings and Mitsubishi UFJ Financial Group, have launched US dollar bond issuances this week, making the global bond market particularly busy. Data shows that Japanese issuers have already issued $93 billion in US dollar and Euro bonds so far this year, a 67% increase compared to the same period last year. The highest annual record for bond issuance by Japanese borrowers is around $98 billion.
7 m ago
Morningstar analyst Vincent Sun reports that due to intense competition in the automotive industry, Ideal Car's overall sales volume may face some pressure. He stated that the company's net profit for the second quarter did not meet Morningstar's expectations. With soft sales guidance for the third quarter, Morningstar expects the company's profitability to continue to be under pressure. The contribution of pure electric vehicle models remains low. The rapid growth in Ideal Car's delivery volume will largely depend on the production increase of its pure electric vehicles in the second half of the year. Morningstar has revised down its sales volume forecast for Ideal Car in 2025 by 14% to account for the sales pace since the beginning of the year as well as the disappointing market performance of the pure electric SUV.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.